Brise Pharmaceuticals Co

Brise Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative analgesic treatments for acute and chronic pain conditions like migraine, neuropathic, and musculoskeletal pain. They have advanced two molecules to the clinical stage and utilize a biology-based drug development platform targeting the Trigeminovascular System (TVS) and Dorsal Root Ganglion (DRG). Their mission is to provide safe, effective, and accessible pain relief solutions.

Buy Funded Startups lists

Funding Round: Pre Series A+

Funding Amount: $20M

Date: 22-Apr-2024

Investors: Shunxi Fund, Cnfuel Capital, Vinner Therapeutics, Qiming Venture Partners, BioTrack Capital, Sherpa Healthcare Partners

Markets: Biotechnology, Pharmaceuticals, Pain Management

HQ: Shanghai, Shanghai, China

Founded: 2021

Website: https://brisepharma.com/news.html

LinkedIn:

Twitter:

Instagram: